Search Results - "Menon, Nandini Sharrel"

Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India by Bajpai, Jyoti, Abraham, George, Saklani, Avanish P, Agarwal, Anshul, Das, Sashanka, Chatterjee, Ambarish, Kapoor, Akhil, Eaga, Prathyusha, Mondal, Pradip Kumar, Chandrasekharan, Arun, Bhargava, Prabhat Ghanshyam, Srinivas, Sujay, Turkar, Siddharth, Rekhi, Bharat, Khanna, Nehal, Janu, Amit Kumar, Bal, Munita, Ostwal, Vikas Sureshchand, Ramaswamy, Anant, Rohila, Jitender, Desouza, Ashwin L, Guha, Amrita, Kumar, Rajiv, Menon, Nandini Sharrel, Rath, Sushmita, Patil, Vijay Maruti, Noronha, Vanita Maria, Joshi, Amit Prakashchandra, Laskar, Siddhartha, Rangarajan, Venkatesh, Prabhash, Kumar, Gupta, Sudeep, Banavali, Shripad

“…Treatment of malignant melanoma has undergone a paradigm shift with the advent of immune checkpoint inhibitors (ICI) and targeted therapies. However, access to…”
Get full text

A mysterious localized spinal whiteout by George Abraham, Nandini Sharrel Menon, Sunil R Chopade, Vanita Noronha, Vijay M Patil, Amit Joshi, Kumar Prabhash

Get full text

A retrospective analysis of patients administered neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin with oral metronomic chemotherapy (OMCT) in locally advanced borderline resectable/technically unresectable head and neck cancers by Pathak, Shruti, Peelay, Zoya, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Chaturvedi, Pankaj, Prabhash, Kumar

“…6030 Background: Neoadjuvant chemotherapy with TPF though the standard is seldom used in India due to its adverse events rate. Two drug regimen of Paclitaxel…”
Get full text

Real-world analysis of BRAF inhibitors with patients positive for BRAF V600E mutations diagnosed with rare tumors by Peelay, Zoya, Patil, Vijay Maruti, Noronha, Vanita, Pathak, Shruti, Menon, Nandini Sharrel, Prabhash, Kumar

“…e15085 Background: BRAF mutation is seen in multiple cancers and BRAF inhibitors have a tumor agnostic nature. However there is very limited real world data…”
Get full text

Real-world analysis of use of lenvatinib in differentiated thyroid cancers by Peelay, Zoya, Pathak, Shruti, Patil, Vijay Maruti, Prabhash, Kumar, Noronha, Vanita, Menon, Nandini Sharrel

“…e18075 Background: Lenvatinib is one of the approved treatments for radioiodine refractory differentiated thyroid cancers. However, there is very limited data…”
Get full text

Efficacy of Gemcitabine in recurrent meningioma: A phase II study by Shah, Devanshee, Menon, Nandini Sharrel, Puranik, Ameya, Choudhary, Amit, Patil, Vijay Maruti, Pathak, Shruti, Peelay, Zoya

“…e14044 Background: Systemic therapy has a limited role in meningiomas. There is in-vivo and in-vitro data that gemcitabine can potentially be useful in…”
Get full text

Real world data of neoadjuvant and adjuvant chemotherapy in head neck osteosarcoma: Experience from a tertiary care center in India by Tongaonkar, Arnav, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Jogdhankar, Shweta, Prabhash, Kumar

“…e18012 Background: The head and neck (HN) region is a rare sub-site of osteosarcoma(OGS), with less than 10% of all cases of osteosarcoma and < 1% of all the…”
Get full text

An audit of neoadjuvant chemotherapy in sinonasal teratocarcinosarcoma from an academic tertiary care centre in India by Peelay, Zoya Ravish, Patil, Vijay Maruti, Noronha, Vanita, Singh, Ajaykumar Chandrabhan, Prabhash, Kumar, Shah, Minit Jalan, Menon, Nandini Sharrel

“…e18109 Background: Sinonasal teratocarcinosarcoma (SNTCS) are rare types of sinonasal malignancies, incidence is approximately 3% of all head and neck cancers…”
Get full text

Patient’s perception of cancer treatment outcomes in geriatric age groups: A retrospective analysis from a tertiary care centre in India by Choudhary, Jatin, Noronha, Vanita, Menon, Nandini Sharrel, Shah, Minit Jalan, Pillai, Anupa, Kumar, Anita, Rao, Abhijith Rajaram, Pawar, Akash, Dhekale, Ratan, Prabhash, Kumar

“…e13774 Background: Geriatric population forms a significant part of the total cancer patients in any given country and their expectations, their needs and…”
Get full text

Prevalence of HRR mutations in Indian patients with mCRPC by Batra, Atul, Menon, Nandini Sharrel, Vaswani, Bharat, Talwar, Vineet, Bajaj, Rajat, Chandrakanth, MV, Hingmire, Sachin Sharadchandra, Prabhash, Kumar, Choudhary, Priyanshu, Pathania, Bhavana

“…183 Background: Prostate cancer is the 12 th most common cancer in India. Almost all patients with metastatic prostate cancer progress to castration-resistant…”
Get full text

Long-term outcomes of a randomized controlled clinical trial comparing the efficacy of cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer by Nawale, Kavita Prakash, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Dhumal, Sachin Babanrao, Bhattacharjee, Atanu, Prabhash, Kumar

“…e18008 Background: Long term outcomes (> 2 years or above) are rarely reported in studies with second line or beyond systemic therapies in head and neck…”
Get full text

Long-term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin ineligible head and neck cancer patients by Kolkur, Manali, Patil, Vijay Maruti, Menon, Nandini Sharrel, Noronha, Vanita, Prabhash, Kumar, Simha, Vijai, Talreja, Vikas, Chandrasekharan, Arun, Dhumal, Sachin

“…e18037 Background: Docetaxel can be administered in several situations like low creatinine clearance or pre-existing grade 3-4 ototoxicity, where cisplatin is…”
Get full text

Checkpoint inhibitor accessibility in 15,000+ Indian patients by Ravikrishna, Madala, Abraham, George, Patil, Vijay Maruti, Bhattacharjee, Atanu, Noronha, Vanita, Menon, Nandini Sharrel, Joshi, Amit, Prabhash, Kumar

“…9012 Background: Access to newer therapies is an issue in low and low middle income countries. Hence we decided to audit our practice in the head and neck and…”
Get full text

Neoadjuvent chemotherapy in rare sinonasal teratocarcinosarcoma: Long-term result from tertiary center by Sharma, Abhishek, Patil, Vijay Maruti, Rai, Rahul Kumar, Saha, Saswata, Noronha, Vanita, Menon, Nandini Sharrel, Joshi, Amit, Prabhash, Kumar

“…e18005 Background: Sinonasal teratocarcinosarcoma (SNTCS) is a rare and highly aggressive disease entity having poor outcomes with available treatment…”
Get full text

Long-term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer by Dhumal, Sachin Babanrao, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Nawale, Kavita Prakash, Mahimkar, Manoj, Prabhash, Kumar

“…e18021 Background: Triple metronomic chemotherapy is one of the options of treatment in platinum-refractory/early failure oral cancer. However long term…”
Get full text

Outcomes and adverse events of low-dose nivolumab in platinum refractory head and neck cancers by Kumar, Hemanth, Choudhary, Jatin, Ravikrishna, Madala, Menon, Nandini Sharrel, Patil, Vijay Maruti, Noronha, Vanita, Prabhash, Kumar, Joshi, Amit

“…6048 Background: Nivolumab is one of the recommended regimens for platinum refractory and second line treatment in head and neck cancers as per NCCN…”
Get full text

10-year outcomes of technically unresectable oral cancers with neoadjuvant chemotherapy: Real-world data and implications for clinical practice by Dhanawat, Aditya, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Singh, Ajaykumar Chandrabhan, Chaturvedi, Pankaj, Pai, Prathamesh S, Chaukar, Devendra A, Laskar, Sarbani Ghosh, Prabhash, Kumar

“…6085 Background: Neo-adjuvant chemotherapy (NACT) followed by response assessment is the standard treatment algorithm for locally advanced oral cavity squamous…”
Get full text

Neoadjuvant chemotherapy followed by definitive chemoradiation in technically unresectable oral cavity squamous cancers by Trikha, Mehak, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Singh, Ajaykumar Chandrabhan, Dhanawat, Aditya, Chaturvedi, Pankaj, Pai, Prathamesh S, Chaukar, Devendra A, Laskar, Sarbani Ghosh, Prabash, Kumar

“…e18073 Background: Definitive Chemoradiation has dismal outcomes in very advanced oral cavity cancers. Surgical resection is the preferred modality of…”
Get full text

Impact of pre-treatment anemia on survival in locally advanced head neck squamous cell carcinomas treated with radiation with or without concurrent chemotherapy by Shah, Minit Jalan, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Singh, Ajaykumar Chandrabhan, Jobanputra, Kunal Naishadh, Peelay, Zoya Ravish, Prabhash, Kumar

“…e18079 Background: Locally advanced head neck squamous cell carcinomas (LAHNSCCs) are treated either with surgery followed by radiation (RT) alone, surgery…”
Get full text

PD-L1 in head and neck cancers: Audit for tertiary care centre in India by Peelay, Zoya Ravish, Mittal, Neha, Patil, Vijay Maruti, Singh, Ajaykumar Chandrabhan, Noronha, Vanita, Prabhash, Kumar, Menon, Nandini Sharrel, Shah, Minit Jalan

“…e14565 Background: There is no data on the expression of Programmed Death Ligand 1 (PD-L1) in Head and Neck cancers (HNC) from the Indian population. Hence,…”
Get full text